Keyphrases
Clinical Trial Phase II
25%
Daily Clinical Practice
50%
Diagnostic Centre
25%
Diagnostic Interventions
50%
Diagnostic Modalities
50%
Enteric Nervous System
75%
Etiology
25%
Everyday Practices
25%
Full-thickness Biopsy
50%
Functional Constipation
100%
Gastrointestinal Problems
25%
Neuropathology
50%
Neurotrophin-3 (NT-3)
50%
Novel Mechanism
25%
Pathophysiologic Mechanisms
50%
Pathophysiology
100%
Patient Well-being
25%
Targeted Therapy
50%
Therapeutic Modalities
25%
Translational Studies
25%
Medicine and Dentistry
Biopsy Technique
50%
Chronic Constipation
100%
Clinical Trial
25%
Gastrointestinal Distress
25%
Intestine Innervation
50%
Neuropathology
50%
Neurotrophin 3
50%
Pathophysiology
100%
Quality of Life
25%
Targeted Therapy
25%
Therapeutic Modality
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Constipation
100%
Clinical Trial
25%
Gastrointestinal Symptom
25%
Neurotrophin 3
50%
Pathophysiology
100%